Stay informed about how semiconductor technologies revolutionize proteomics

Are we on the verge of a decisive breakthrough in proteomics? There are strong indications that we are: investments in the field are rapidly increasing, and technological advancements are progressing at an accelerated pace.

However, several challenges remain. Due to its staggering complexity, the proteome is much more difficult to digitize than the genome. Unraveling it requires a range of novel technologies that must be reliable, high-throughput, and sensitive. To bring these technologies into clinical use, they also need to be compact and suitable for mass production.

Imec leverages its expertise and infrastructure to help accelerate this proteomics revolution. We drive innovation through our own research, and by collaborating with other key players in the field to identify the most significant challenges and opportunities.

Would you like to follow along on this journey and stay updated on the latest developments in this exciting field? Fill in the form below to receive regular updates via email.